Team:ITESM-Guadalajara/Laws
From 2014.igem.org
(Difference between revisions)
Lizsánchez (Talk | contribs) |
|||
(2 intermediate revisions not shown) | |||
Line 222: | Line 222: | ||
.faceBot{ | .faceBot{ | ||
- | background: | + | background: #202020; |
} | } | ||
Line 364: | Line 364: | ||
<a href="https://2014.igem.org/Main_Page"> | <a href="https://2014.igem.org/Main_Page"> | ||
<span>iGEM 2014</span> | <span>iGEM 2014</span> | ||
+ | <span class="green-effect"></span> | ||
+ | </a> | ||
+ | </li><li class="menu-item"> | ||
+ | <a href="https://2014.igem.org/Team:ITESM-Guadalajara/Notebook"> | ||
+ | <span>Notebook</span> | ||
<span class="green-effect"></span> | <span class="green-effect"></span> | ||
</a> | </a> | ||
Line 422: | Line 427: | ||
<p align="justify">Mexico is a member of the World Trade Organization (WTO) and it is also an active member of the Cartagena Protocol. Its participation in these organizations should facilitate and enable the transit of living modified organisms (LMO), genetically modified organisms (GMOs) and equipment or samples needed to investigate and / or develop any of the organisms mentioned before. | <p align="justify">Mexico is a member of the World Trade Organization (WTO) and it is also an active member of the Cartagena Protocol. Its participation in these organizations should facilitate and enable the transit of living modified organisms (LMO), genetically modified organisms (GMOs) and equipment or samples needed to investigate and / or develop any of the organisms mentioned before. | ||
The Secretary of Health and COFEPRIS are responsible for the regulation, information giving, and product verification regarding biological material, such as DNA, bacteria and hormones.</p><p align="justify"> | The Secretary of Health and COFEPRIS are responsible for the regulation, information giving, and product verification regarding biological material, such as DNA, bacteria and hormones.</p><p align="justify"> | ||
- | Being the import process of genetic material a time-consuming and ambiguous process, where the final decision of retaining or releasing this material lies in the customs agents; it is proposed to clearly classify products as hormones, bacteria or DNA, and the presentation in which these products are being transported through a guide containing labeling and necessary paperwork specifications to complete the import process without problems.</p> | + | Being the import process of genetic material a time-consuming and ambiguous process, where the final decision of retaining or releasing this material lies in the customs agents; it is proposed to clearly classify products as hormones, bacteria or DNA, and the presentation in which these products are being transported through a guide containing labeling and necessary paperwork specifications to complete the import process without problems.</p><p align="justify"> |
In case the biological material to be imported does not contain a complete labeling because these products do not contain large specifications on the label, the provider must submit a commitment letter, in which it is ensured that the material being imported into that presentation is risk free and safe. It is also proposed to establish an official standard for labeling, packaging, distribution and transport that specifies:</p> | In case the biological material to be imported does not contain a complete labeling because these products do not contain large specifications on the label, the provider must submit a commitment letter, in which it is ensured that the material being imported into that presentation is risk free and safe. It is also proposed to establish an official standard for labeling, packaging, distribution and transport that specifies:</p> | ||
<p align="justify"> | <p align="justify"> |
Latest revision as of 01:49, 18 October 2014